Table 1.
Scar > 1 % | p-value | Control | p-value | Mixed | p-value | |
---|---|---|---|---|---|---|
(N = 125) | (n = 57) | LGE-Ctrl | (n = 23) | Ctrl-Mix | (n = 45) | Mix-LGE |
LVEDV, mL | 168 ± 40 | 0.076 | 148 ± 26 | NS | 145 ± 36 | 0.007 |
LVESV, mL | 82 ± 38 | <0.001 | 50 ± 15 | NS | 54 ± 23 | <0.001 |
LVEF, % | 52 ± 13 | <0.001 | 66 ± 6 | NS | 62 ± 9 | <0.001 |
LVmass, g | 60 ± 13 | 0.073 | 52 ± 7 | NS | 56 ± 14 | 0.345 |
LVscar, % | 9 ± 8 | N/A | N/A | N/A | 0.6 ± 2 | <0.001 |
Left ventricular end-diastolic (LVESV) and end-systolic volumes (LVESV) (mL), left ventricular ejection fraction (LVEF), left ventricular mass corrected for body surface area (LVmass) (gram) and the scar volume fraction of the left ventricle (%). Mean value ± standard deviation, ANOVA with Bonferroni post hoc test, N/A = Not Applicable. Table 2 - Global strain values for patients with any segment scar > 50 % and the no scar control group